Replies to post #133210 on Biotech Values

[DewDiligence]

Interesting development insofar as Synthon is not one of the big names in generic drugs. If they’re lucky, they might get an FDA response by 2016.

[pcrutch]

Another company with some IP on Copaxone would be ScinoPharm. I believe Watson owns a good chunk of this private Taiwanese company.

They've got a few patents and applications with respect to analyzing and synthesizing Glatiramer Acetate.

Process for the preparation of a polypeptide
http://www.google.com/patents/US20090035816?dq=%22scinopharm%22+polypeptides&ei=3d3sTsCLLon0ggeMh8n4CA

Methods of Analyzing Peptide Mixtures
http://www.google.com/patents/US20100285513?dq=%22scinopharm%22+polypeptides&ei=3d3sTsCLLon0ggeMh8n4CA

Methods for Chemical Equivalence in Characterizing of Complex Molecules
http://www.google.com/patents?id=QdDoAQAAEBAJ&pg=PA57&dq=%22scinopharm%22+polypeptides&hl=en&sa=X&ei=3d3sTsCLLon0ggeMh8n4CA&ved=0CDgQ6AEwAg#v=onepage&q=%22scinopharm%22%20polypeptides&f=false

Synthesis of Glatiramer Acetate
http://www.google.com/patents?id=ERnMAAAAEBAJ&pg=PA1&dq=%22scinopharm%22+polypeptides&hl=en&sa=X&ei=3d3sTsCLLon0ggeMh8n4CA&ved=0CDsQ6AEwAw#v=onepage&q=%22scinopharm%22%20polypeptides&f=false